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*HQHUDO ,QIRUPDWLRQ 4-Chloropyridine hydrochloride was purchased from Fluka. 
Manganese(IV)-oxide was purchased from Merck. Other chemicals were purchased from Aldrich. 
Microwave reactions were performed in a Biotage Initiator 2.5 microwave reactor. Melting points 
were determined using a Boetius PMHK apparatus (Carl Zeiss, Germany) and were not corrected.  
IR spectra were recorded on a Perkin-Elmer spectrophotometer FTIR 1725X.  1H and 13C NMR 
spectra were recorded on a Varian Gemini-200 spectrometer (at 200 and 50 MHz, respectively), and 
a Bruker Ultrashield Advance III spectrometer (at 500 and 125 MHz, respectively) employing 
indicated solvents (vide infra) using TMS as the internal standard.  Chemical shifts are expressed in 
ppm (į) values and coupling constants (J) in Hz.  ESI–MS (HRMS) spectra of the synthesized 
compounds were acquired on a Agilent Technologies 1200 Series instrument  equipped with a 
Zorbax Eclipse Plus C18 (100 u 2.1 mm i.d. 1.8 ȝm) column and DAD detector (190-450 nm) in 
combination with a 6210 Time-of-Flight LC/MS instrument in positive ion mode.  The samples 
were dissolved in pure MeOH (HPLC grade).  The selected values were as follows: capillary 
voltage = 2.5 kV, gas temperature = 250°C, drying gas = 7 L min-1, nebulizer pressure = 30 psig, 
and fragmentator voltage = 50 V. GC/MS spectra of the synthesized compounds were acquired on a 
Agilent Technologies 7890A equipped with a DB-5 MS (30 m × 0.25 mm × 0.25 ȝm) column and 
5975C MSD and FID detector. The selected values were as follows: carrier gas was He (1.0 
mL/min), temperature linearly increased 40-315 oC  (10 oC/min), injection volume = 1 ȝL, 
temperature = 250 °C, temperature (FID detector) = 300 °C, and EI mass spectra range: 40-550 m/z. 
Lobar LichroPrep Si 60 (40-63 ȝm) or LichroPrep RP-18 columns (Merck, Germany), coupled to a 
Waters RI 401 detector, were used for preparative column chromatography. Thin-layer 
chromatography was performed on pre-coated Merck silica gel 60 F254 and Merck RP-18 F254 
plates. The solution MeOH (NH3) stands for combination MeOH/NH3 aq = 9:1, and the solution 









To a solution of iPr2NH (0.670 mL, 4.78 mmol) in THF (2.0 mL) 1.6 M n-BuLi in hexane (2.43 
mL, 3.90 mmol) was added dropwise at -78 °C under Ar. After stirring for 5 min at 0 °C the 
mixture was cooled to -78 °C and used in the next reaction. To a suspension of 4-chloropyridine 
hydrochloride (500 mg, 3.33 mmol) in dry THF (5 mL) 1.6 M n-BuLi in hexane (2.10 mL, 3.33 
mmol) was added dropwise at 0 °C under Ar. After stirring at room temperature for 30 min the 
reaction was cooled to -78 °C and prepared LDA solution was addded. Upon stirring at the same 
temperature for 30 min DMF (380 μL, 4.95 mmol) was added. The reaction was warmed to room 
temperature gradually and stirred overnight. It was quenched with 3 M HCl and resulting mixture 
was stirred for 2 h at r.t. The solution was neutralized with NaHCO3, it was extracted with CH2Cl2, 
dried over Na2SO4, and evaporated to give crude aldehyde as brown oil. The obtained aldehyde was 
dissolved into MeOH (25 mL), and NaBH4 (187 mg, 4.95 mmol) was added to the solution. After 
stirring for 3 h at room temperature, the reaction was concentrated. Water was added to the residue, 
and extracted with CH2Cl2, followed by drying over anh. Na2SO4, and evaporation to dryness. 
Column chromatography using hexane/EtOAc = 8:2 afforded desired compound  as pale yellow 
powder (206 mg, 43%), mp = 87-90 °C. 1H NMR (200 MHz, CDCl3) G 8.65 (s, 1H), 8.37 (d, J = 5.6 
Hz, 1H), 7.30 (d, J = 5.6 Hz, 1H), 4.82 (s, 2H), 4.43 (s, 1H). 13C NMR (50 MHz, CDCl3)G 149.4, 
149.1, 143.0, 134.8, 124.4, 60.0. IR (ATR): 3176, 2925, 2853, 1582, 1563, 1468, 1443, 1405, 1359, 




To a solution of alcohol  (0.80 g, 5.6 mmol) in CH2Cl2 (45 mL) PBr3 (1.0 mL, 11 mmol) was 
added. After stirring for 2 h at room temperature the reaction mixture was cooled to 0 °C it was 
neutralized with NaHCO3, extracted with CH2Cl2, dried over Na2SO4, and evaporated to dryness. 
Column chromatography using hexane/EtOAc = 1:1 afforded product as red oil. Obtained 
intermediate was disolved in PhMe (18 mL) and PPh3 (1.5 g, 5.9 mmol) was added. Resulting 
reaction mixture was refluxed for 6 days. After cooling to room temperature, product was filtered, 
washed with diethyl ether and dried under reduced pressure at 45 °C. Desired phosphonium 
bromide was obtained as white powder (1.2 g, 46%).1H NMR (500 MHz, CDCl3) į 8.69 (s, 1H), 
8.41 (s, 1H), 7.88-7.60 (m, 15H), 7.20-7.13 (m, 1H), 5.84 (d, J = 14.5 Hz, 2H). 13C NMR (125 
MHz, CDCl3) į 153.1 (d, J = 5.5 Hz) , 150.4 (d, J = 3.6 Hz), 145.6 (d, J = 5.5 Hz), 135.4 (d, J = 2.6 
Hz), 134.2 (d, J = 10.0 Hz), 130.4 (d, J = 12.5 Hz), 124.3, 123.3, 117.1 (d, J = 84.8 Hz), 26.2 (d, J = 
49.6 Hz). IR (ATR): 2998, 2861, 2838, 2769, 1644, 1556, 1481, 1435, 1402, 1319, 1191, 1159, 






                                                 
1 Takano, Y.; Shiga, F.; Asano, J.; Ando, N.; Uchiki, H.; Fukuchi, K.;Anraku, T. Bioorg. Med. Chem. , 13, 5841. 
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%URPREHQ]HQH\OPHWKDQRO
2-Bromobenzaldehyde (1.26 mL, 10.8 mmol) was dissolved in MeOH (25 mL), and NaBH4 (491 
mg, 12.9 mmol) was added to the solution. After stirring for 18 h at room temperature, the reaction 
mixture was concentrated. Water was added to the residue and the product was extracted with 
CH2Cl2, organic layer was dried over Na2SO4, and evaporated. The desired product was obtained as 
pale yellow oil (2.00 g,  99%) and was used without any further purifications. 1H NMR (200 MHz, 
CDCl3) į 7.58-7.42 (m, 2H), 7.38-7.24 (m, 1H), 7.22-7.10 (m, 1H), 4.72 (s, 2H), 2.31 (s, 1H). 13C 
NMR (50 MHz, CDCl3) į 139.7, 132.6, 129.1, 128.8, 127.6, 122.5, 65.0. GC-MS (m/z (%)): 186.0 
([M]+ (43)), 169.0 (5), 157.0 (10), 107.1 (70), 89.1 (11), 79.0 (100). IR (ATR): 3992, 3970, 3912, 
3892, 3857, 3304, 3078, 2910, 2858, 2710, 2577, 2029, 1965, 1567, 1466, 1439, 1364, 1264, 1244, 




(2-Bromobenzene-1-yl)methanol (2.00 g, 10.7 mmol) was dissolved in CH2Cl2 (100 mL), and  PBr3 
(2.00 mL, 21.3 mmol) was added. After stirring for 2 h at room temperature resulting reaction 
mixture was cooled to 0 °C, neutralized with NaHCO3, extracted with CH2Cl2, dried over Na2SO4, 
and evaporated to dryness. Column chromatography using hexane/EtOAc = 8:2 afforded product as 
pale red oil 1.70 g. Product was dissolved in PhMe (75 mL) followed by addition of PPh3 (1.97 g, 
7.62 mmol). Resulting reaction mixture was refluxed for 6 days. After cooling to room temperature, 
product was filtered off, washed well with diethyl ether and dried under reduced pressure at 45 °C. 
Phosphonium salt  was obtained as white powder, 3.30 g (60%). 1H NMR (500 MHz, CDCl3) į 
7.80-7.72 (m, 3H), 7.65-7.56 (m, 12H), 7.49-7.44 (m, 1H), 7.35-7.30 (m, 1H), 7.14-7.06 (m, 2H), 
5.52 (d, J = 14.5 Hz, 2H).13C NMR (125 MHz, CDCl3) į 135.1 (d, J = 2.7 Hz), 134.1 (d, J = 10.0 
Hz), 132.8, 132.8, 130.1 (d, J = 12.6 Hz), 128.2 (d, J = 3.5 Hz), 127.4 (d, J = 9.1 Hz), 127.0 (d, J = 
7.2 Hz), 116.9 (d, J = 84.9 Hz), 30.8 (d, J = 48.8 Hz). IR (ATR): 3038, 3015, 2984, 2941, 2855, 





Alcohol  (92 mg, 0.65 mmol) was dissolved in CH2Cl2 (5 mL) followed by addition of MnO2 (0.56 
g, 6.5 mmol). After stirring for 2 h at room temperature reaction mixture was filtered and solvent 
was evaporated to dryness. The obtained 4-chloropyridine-3-carbaldehyde was found to be 






To a suspension of phosphonium salt(338 mg, 0.660 mmol) in THF (5 mL) was added prepared 
LDA (0.40 mL, 0.78 mmol). After 30 min 4-chloropyridine-3-carbaldehyde (92 mg, 0.65 mmol) 
dissolved in THF (1 mL) was added over 5 min. The reaction mixture was stirred at room 
temperature and after 16 h it was quenched with NaHCO3. The aqueous phase was separated and 
extracted with EtOAc (3 × 10 mL). The organic extracts were combined, dried over Na2SO4, 
concentrated in vacuum and purified by column chromatography (RP, CH2Cl2 (PhMe)/MeOH = 
7:3) to yield (Z)- (104 mg, 54%), and (E)- (24 mg, 12%).
(Z)-: light yellow solid, mp 40-41 oC. 1H NMR (500 MHz, CDCl3) G 8.29 (d, J = 5.3 Hz, 1H), 8.16 
(s, 1H), 7.61-7.56 (m, 1H), 7.31 (d, J = 5.3 Hz, 1H), 7.12-7.03 (m, 2H), 6.98-6.90 (m, 1H), 6.93 (d, 
J = 12.0 Hz, 1H) 6.75 (d, J = 12.0 Hz, 1H). 13C NMR (125 MHz, CDCl3) G 151.2, 148.7, 143.2, 
136.4, 133.4, 132.9, 131.5, 130.4, 129.2, 127.2, 124.8, 124.2, 123.9. IR (ATR): 3084, 3057, 3031, 
1572, 1544, 1459, 1400, 1076, 1044, 961, 820, 789, 751, 691 cm-1. (+)ESI-HRMS (m/z) [M + H]+  
293.96877 (error 2.73 ppm).  
(E)-: white solid, mp = 46-48 oC 1H NMR (500 MHz, CDCl3) G 8.92 (s, 1H), 8.40 (d, J = 5.3 Hz, 
1H), 7.71 (dd, J = 7.8 Hz, J = 1.4 Hz, 1H), 7.62 (dd, J = 8.0 Hz, J = 0.9 Hz, 1H), 7.56 (d, J = 16.0 
Hz, 1H), 7.38-7.33 (m, 2H), 7.30 (d, J = 16.0 Hz, 1H), 7.22-7.16 (m, 1H). 13C NMR (125 MHz, 
CDCl3) G 149.0, 148.3, 142.4, 136.3, 133.2, 131.7, 131.5, 129.7, 127.6, 127.1, 124.5, 124.4, 124.1. 
IR (ATR): 3059, 2931, 2856, 1632, 1568, 1544, 1469, 1432, 1402, 1323, 1281, 1220, 1117, 1074, 
1022, 958, 816, 750 cm-1. GC-MS, RT 24.00 min (m/z (%)): 294.9 ([M]+ (100)), 214.0 (78), 179.0 
(74), 151.0 (67), 126.0 (14), 107.0 (17), 89.0 (12), 76.0 (29), 63.0 (15), 51.0 (9). (+)ESI-HRMS 




The phosphonium salt(1.0 g, 2.1 mmol) and 4-chloropyridine-3-carbaldehyde (0.30 g, 2.1 mmol) 
were transformed into (Z)- (0.23 g, 43%), and (E)- (12 mg, 2%) using freshly prepared LDA (2.0 
mL, 4.0 mmol). The crude products were purified using preparative column chromatography (SiO2, 
hexane/EtOAc = 8:2). 
(Z)- light yellow powder, mp 130-131 oC. 1H NMR (500 MHz, CDCl3) G 8.34 (d, J = 5.5 Hz, 1H), 
8.14 (s, 1H), 7.34 (d, J = 5.5 Hz, 1H), 6.90 (s, 1H). 13C NMR (125 MHz, CDCl3) G 150.7, 149.4, 
143.4, 131.2, 127.6, 124.5. IR (KBr): 3431, 3041, 2928, 2856, 1631, 1571, 1550, 1463, 1401, 1301, 
1219, 1193, 1075, 972, 870, 816 cm-1. (+)ESI-HRMS (m/z) [M + 2H]2+  126.00988 (error -4.92 
ppm), [M + H]+  251.01382 (error 0.38 ppm). 
(E)-: white solid, mp = 127-129 oC. 1H NMR (CDCl3, 500 MHz) G 8.91 (s, 1H), 8.44 (d, J = 5.5 
Hz, 1H), 7.45 (s, 1H), 7.37 (dd, J = 5.5 Hz, J = 0.5 Hz, 1H). 13C NMR (CDCl3, 125 MHz) G 149.6, 
148.3, 142.8, 131.1, 125.9, 124.6. IR (ATR): 3098, 3048, 2958, 2930, 2866, 1896, 1636, 1573, 
1549, 1474, 1408, 1315, 1223, 1175, 1073, 962, 839, 814, 740 cm-1. GC-MS, RT 23.29 min (m/z 
(%)): 249.9 ([M]+ (100)), 214.9 (46), 188 (16), 179.0 (15), 152.0 (14), 126.0 (13), 99.0 (9), 75.0 







Reaction tube containing a stirring bar was evacuated and backfilled with Ar. The tube was then 
charged with Pd(OAc)2 (5 mol %), JohnPhos (10 mol %) and NaOt-Bu (2.8 eq) and filled with Ar. 
Toluene was added. After stirring at room temperature for 5 min, aryl halide (1 eq) and amine (3 eq) 
were added, tube was filled with Ar and capped. Reaction mixture was heated to 100 °C and stirred 
at same temperature. Products were purified by preparative column chromatography: SiO2, 
CH2Cl2/MeOH (NH3) = 9/1. 
NN'LPHWK\OHS\ULGR>b@>@EHQ]D]HSLQ\OSURSDQDPLQH  
Following general procedure, a mixture of  (24 mg, 0.080 mmol), 3-dimethylamino-1-propylamine 
(30 PL, 0.24 mmol), sodium tert-butoxide (22 mg, 0.23 mmol), Pd(OAc)2 (0.9 mg, 5 mol %), 
JohnPhos (2.4 mg, 10 mol %) and toluene (1.5 mL) was stirred at 100 °C for 48 hours.  yellow 
oil (18 mg, 81%). 1H NMR (500 MHz, CDCl3) į 8.35 (d, J = 5.5 Hz, 1H), 8.17 (s, 1H), 7.30-7.22 
(m, 1H), 7.05-6.98 (m, 2H), 6.94 (d, J = 8.5 Hz, 1H), 6.81 (d, J = 5.5 Hz, 1H), 6.74 (d, J = 11.5 Hz, 
1H), 6.60 (d, J = 11.5 Hz, 1H), 3.80-3.73 (m, 2H), 2.39-2.33 (m, 2H), 2.15 (s, 6H), 1.82-1.70 (m, 
2H); 13C NMR (125 MHz, CDCl3) į 158.8, 150.5, 150.1, 149.1, 134.1, 133.6, 129.5, 129.3, 129.2, 
129.1, 124.1, 121.1, 114.7, 57.1, 48.2, 45.5, 25.4. IR (ATR): 3413, 3023, 2944, 2858, 2817, 2767, 
1635, 1578, 1481, 1419, 1392, 1332, 1244, 1184, 1123, 1060, 919, 831, 794, 766 cm-1. (+)ESI-
HRMS (m/z) [M + H]+ 280.18125 (error: 1.51 ppm). 
 
 
>0RUSKROLQ\OSURS\O@HS\ULGR>b@>@EHQ]D]HSLQH  Following general 
procedure, a mixture of  (24 mg, 0.080 mmol), N-(3-aminopropyl)morpholine (36 PL, 0.24 mmol), 
sodium tert-butoxide (22 mg, 0.23 mmol), Pd(OAc)2 (0.9 mg, 5 mol %), JohnPhos (2.4 mg, 10 mol 
%) and toluene (1.5 mL) was stirred at 100 °C for 48 hours.  yellow oil (16 mg, 61%). 1H NMR 
(500 MHz, CDCl3) į 8.35 (d, J = 6.0 Hz, 1H), 8.17 (s, 1H), 7.29-7.24 (m, 1H), 7.05-7.00 (m, 2H), 
6.94 (d, J = 8.5 Hz, 1H), 6.80 (d, J = 5.5 Hz, 1H), 6.73 (d, J = 11.5 Hz, 1H), 6.59 (d, J = 11.5 Hz, 
1H), 3.80-3.75 (m, 2H), 3.70-3.60 (m, 4H), 2.47-2.40 (m, 2H), 2.39-2.30 (m, 4H), 1.80-1.70 (m, 
2H); 13C NMR (125 MHz, CDCl3) į 158.8, 150.5, 150.1, 149.0, 134.1, 133.6, 129.5, 129.3, 129.2, 
124.1, 121.1, 114.7, 66.9, 56.2, 53.7, 48.2, 24.2. IR (ATR): 3268, 3025, 2956, 2854, 2812, 2687, 
1640, 1576, 1523, 1479, 1395, 1332, 1307, 1184, 1141, 1118, 1068, 914, 765, 735, 700 cm-1. 




NN'LHWK\OHS\ULGR>b@>@EHQ]D]HSLQ\OSURSDQDPLQH  Following general 
procedure, a mixture of  (24 mg, 0.080 mmol), 3-diethylamino-1-propylamine (38 PL, 0.24 
mmol), sodium tert-butoxide (22 mg, 0.23 mmol), Pd(OAc)2 (0.9 mg, 5 mol %), JohnPhos (2.4 mg, 
10 mol %) and toluene (1.5 mL) was stirred at 100 °C for 48 hours.  yellow oil (20 mg, 79%). 1H 
NMR (500 MHz, CDCl3) į 8.36 (d, J = 5.5 Hz, 1H), 8.18 (s, 1H), 7.29-7.24 (m, 1H), 7.05-6.98 (m, 
2H), 6.94 (d, J = 8.0 Hz, 1H), 6.81 (d, J = 6.0 Hz, 1H), 6.74 (d, J = 11.5 Hz, 1H), 6.60 (d, J = 11.0 
Hz, 1H), 3.80-3.73 (m, 2H), 2.62-2.55 (m, 2H), 2.51-2.42 (m, 4H), 1.79-1.70 (m, 2H), 0.98-0.80 (m, 
6H); 13C NMR (125 MHz, CDCl3) į 158.8, 150.4, 150.1, 149.0, 134.1, 133.6, 129.5, 129.3, 129.2, 
129.1, 124.1, 121.2, 114.7, 49.6, 48.1, 46.8, 24.2, 11.3. IR (ATR): 3371, 3200, 2974, 1675, 1581, 
1478, 1395, 1342, 1244, 1184, 1128, 794, 766, 651 cm-1. (+)ESI-HRMS (m/z) [M + 2H]2+ 
154.60980 (error: 0.62 ppm), [M + H]+ 308.21276 (error: 2.05 ppm). 
 
 
NN'LPHWK\O>HS\ULGR>b@>@EHQ]D]HSLQ\OHWKR[\@HWKDQDPLQH  Following 
general procedure, a mixture of  (24 mg, 0.080 mmol), 2-(2-dimethylamino-ethoxy)-ethylamine 
(35 PL, 0.24 mmol), sodium tert-butoxide (22 mg, 0.23 mmol), Pd(OAc)2 (0.9 mg, 5 mol %), 
JohnPhos (2.4 mg, 10 mol %) and toluene (1.5 mL) was stirred at 100 °C for 48 hours.  yellow 
oil (15 mg, 61%). 1H NMR (500 MHz, CDCl3) į 8.36 (d, J = 6.0 Hz, 1H), 8.18 (s, 1H), 7.30-7.25 
(m, 1H), 7.06-7.01 (m, 2H), 6.97 (d, J = 8.0 Hz, 1H), 6.84 (d, J = 5.5 Hz, 1H), 6.74 (d, J = 11.5 Hz, 
1H), 6.60 (d, J = 11.5 Hz, 1H), 4.00-3.93 (m, 2H), 3.64-3.59 (m, 2H), 3.54-3.49 (m, 2H), 2.50-2.45 
(m, 2H), 2.25 (s, 6H); 13C NMR (125 MHz, CDCl3) į 158.6, 150.5, 150.1, 148.9, 134.2, 133.5, 
129.6, 129.4, 129.1, 129.0, 124.3, 121.0, 114.6, 69.0, 68.2, 58.6, 50.0, 45.5.IR (ATR): 3397, 3025, 
2943, 2867, 2821, 2774, 1673, 1578, 1482, 1461, 1395, 1329, 1249, 1186, 1126, 1061, 916, 835, 











Following general procedure, a mixture of  (150 mg, 0.597 mmol), 3-dimethylamino-1-
propylamine (225 PL, 1.80 mmol), sodium tert-butoxide (161 mg, 1.68 mmol), Pd(OAc)2 (6.7 mg, 
5 mol %), JohnPhos (18 mg, 10 mol %) and toluene (7.5 mL) was stirred at 100 °C for 24 hours. 
 yellow oil 146 mg (87%). 1H NMR (500 MHz, CDCl3) į 8.39 (d, J = 5.5 Hz, 2H), 8.16 (s, 2H), 
6.77 (d, J = 5.5 Hz, 2H), 6.64 (s, 2H), 3.78-3.69 (m, 2H), 2.39-2.33 (m, 2H), 2.16 (s, 6H), 1.81-1.72 
(m, 2H). 13C NMR (125 MHz, CDCl3) į 157.1, 150.7, 150.7, 131.1, 128.6, 115.4, 56.7, 47.8, 45.5, 
25.0. IR (film): 3382, 2948, 2864, 2823, 2780, 1641, 1579, 1479, 1398, 1335, 1248, 1176, 1062, 











f@D]HSLQH  Following general 
procedure, a mixture of  (40 mg, 0.16 mmol), N-(3-aminopropyl)morpholine (70 PL, 0.48 mmol), 
sodium tert-butoxide (43 mg, 0.45 mmol), Pd(OAc)2 (1.8 mg, 5 mol %), JohnPhos (4.8 mg, 10 mol 
%) and toluene (2.5 mL) was stirred at 100 °C for 24 hours.  yellow oil (36 mg, 69%). 1H NMR 
(500 MHz, CDCl3) į 8.39 (d, J = 5.5 Hz, 2H), 8.16 (s, 2H), 6.76 (d, J = 5.5 Hz, 2H), 6.63 (s, 2H), 
3.81-3.76 (m, 2H), 3.66–3.57 (m, 4H), 2.48-2.41 (m, 2H), 2.40-2.34 (m, 4H) 1.82-1.74 (m, 2H); 13C 
NMR (125 MHz, CDCl3) į 157.1, 150.8, 131.2, 128.7, 115.4, 66.9, 55.8, 53.8, 47.8, 24.0. IR 
(ATR): 3627, 3386, 3028, 2954, 2854, 2812, 2687, 1672, 1638, 1576, 1480, 1397, 1334, 1252, 
1178, 1140, 1117, 1064, 920, 843, 780, 735 cm-1. (+)ESI-HRMS (m/z) [M+2H]2+, 162.09687 (error 











f@D]HSLQ\ONNGLHWK\OSURSDQDPLQH  Following general 
procedure, a mixture of  (20 mg, 0.080 mmol), 3-diethylamino-1-propylamine (38 PL, 0.24 
mmol), sodium tert-butoxide (22 mg, 0.23 mmol), Pd(OAc)2 (0.9 mg, 5 mol %), JohnPhos (2.4 mg, 
10 mol %) and toluene (1.5 mL) was stirred at 100 °C for 24 hours.  yellow oil (12 mg, 47%). 1H 
NMR (500 MHz, CDCl3) į 8.39 (d, J = 5.5 Hz, 2H), 8.16 (s, 2H), 6.76 (d, J = 5.5 Hz, 2H), 6.64 (s, 
2H), 3.80-3.74 (m, 2H), 2.56-2.49 (m, 2H), 2.48-2.39 (m, 4H), 1.78-1.64 (m, 2H), 0.98-0.90 (m, 
6H); 13C NMR (125 MHz, CDCl3) į 157.2, 150.8, 150.8, 131.2, 128.7, 115.5, 49.6, 47.8, 47.1, 24.6, 
11.7. IR (ATR): 3354, 3166, 2821, 1652, 1470, 1398, 1154, 1050, 1007, 878, 830 cm-1. (+)ESI-





f@D]HSLQ\OHWKR[\@NNGLPHWK\OHWKDQDPLQH  Following 
general procedure, a mixture of  (20 mg, 0.080 mmol), 2-(2-dimethylamino-etoxy)-ethylamine (35 
PL, 0.24 mmol), sodium tert-butoxide (22 mg, 0.23 mmol), Pd(OAc)2 (0.9 mg, 5 mol %), JohnPhos 
(2.4 mg, 10 mol %) and toluene (1.5 mL) was stirred at 100 °C for 24 hours.  yellow oil (13 mg, 
54%). 1H NMR (500 MHz, CDCl3) į 8.40 (d, J = 5.5 Hz, 2H), 8.17 (s, 2H), 6.78 (d, J = 5.5 Hz, 
2H), 6.64 (s, 2H), 3.99-3.94 (m, 2H), 3.68-3.62 (m, 2H), 3.53-3.47 (m, 2H), 2.46-2.41 (m, 2H), 2.22 
(s, 6H); 13C NMR (125 MHz, CDCl3) į 156.9, 150.9, 150.8, 131.2, 128.6, 115.3, 69.4, 67.8, 58.8, 
49.6, 45.8. IR (ATR): 3408, 2947, 2873, 2825, 2781, 1665, 1581, 1485, 1400, 1333, 1254, 1176, 
1127, 1064, 929, 844, 800, 738 cm-1. (+)ESI-HRMS (m/z) [M+2H]2+, 156.09666 (error -1.90), 







Reaction tube containing a stirring bar was evacuated and backfilled with Ar. The tube was charged 
with Pd(OAc)2 (5 mol %), dppf (10 mol %), NaOt-Bu (1.2 eq), aryl halide (1 eq) and KSCOCH3 
(1.2 eq) and evacuated and backfilled with Ar. The flask was capped with a rubber septum, and 
toluene was added. The reaction mixture was heated in a Biotage Initiator 2.5 microwave at 175 oC 
for 90 min. After completion, the reaction mixture was cooled to room temperature. Products were 
purified by preparative column chromatography: SiO2, Hexane/EtOAc = 1/1. 
 
 
>@%HQ]RWKLHSLQR>c@S\ULGLQH Following general procedure, a mixture of  (35 mg, 0.12 
mmol), KSCOCH3 (16 mg, 0.14 mmol), sodium tert-butoxide (14 mg, 0.14 mmol), Pd(OAc)2 (1.3 
mg, 5 mol %), dppf (6.6 mg, 10 mol %) and toluene (1.5 mL) was heated in a Biotage Initiator 2.5 
microwave at 175 oC for 90 min.  white solid (13 mg, 51%), mp 80-82 oC. 1H NMR (CDCl3, 500 
MHz) G 8.48-8.44 (m, 2H), 7.48-7.44 (m, 1H), 7.36-7.28 (m, 3H), 7.28-7.24 (m, 1H), 7.13 (d, J = 
12.5 Hz, 1H), 6.99 (d, J = 12.5 Hz, 1H). 13C NMR (CDCl3, 125 MHz) G 149.9, 149.8, 144.7, 139.7, 
136.1, 135.4, 133.0, 132.7, 130.4, 129.9, 129.7, 128.7, 126.3. IR (ATR): 3056, 3025, 2927, 2855, 
1738, 1629, 1563, 1538, 1471, 1442, 1416, 1389, 1306, 1275, 1174, 1056, 885, 836 cm-1. (+)ESI-
HRMS (m/z) [M + H]+  212.05209 (error -3.58 ppm). 
 
 
7KLHSLQR>cc'@GLS\ULGLQHFollowing general procedure, a mixture of  (30 mg, 0.12 
mmol), KSCOCH3 (16 mg, 0.14 mmol), sodium tert-butoxide (14 mg, 0.14 mmol), Pd(OAc)2 (1.3 
mg, 5 mol %), dppf (7 mg, 10 mol %) and toluene (1.5 mL) was heated in a Biotage Initiator 2.5 
microwave at 175 oC for 90 min.  white solid (12 mg, 49%), mp 139-140 oC. 1H NMR (CDCl3, 
500 MHz) G 8.51 (d, J = 5.0 Hz, 2H), 8.47 (s, 2H), 7.32 (d, J = 5.0 Hz, 2H), 7.08 (s, 2H). 13C NMR 
(CDCl3, 125 MHz) G 150.6, 150.3, 142.9, 134.9, 132.8, 126.6. IR (film): 3024, 2930, 1565, 1542, 
1473, 1390, 1294, 1268, 1178, 1047, 885, 835 cm-1. (+)ESI-HRMS (m/z) [M + H]+  213.04721 
(error -4.14 ppm).
hdovsaa003
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